Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Related Articles by Review for PubMed (Select 11807147)

1.

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, Van Den Neste E, Salles G, Gaulard P, Reyes F, Lederlin P, Gisselbrecht C.

N Engl J Med. 2002 Jan 24;346(4):235-42.

2.

Rituximab: a review of its use in chronic lymphocytic leukaemia, low-grade or follicular lymphoma and diffuse large B-cell lymphoma.

Keating GM.

Drugs. 2010 Jul 30;70(11):1445-76. doi: 10.2165/11201110-000000000-00000. Review.

PMID:
20614951
3.

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

Plosker GL, Figgitt DP.

Drugs. 2003;63(8):803-43. Review.

PMID:
12662126
4.

Rituximab (MabThera) for aggressive non-Hodgkin's lymphoma: systematic review and economic evaluation.

Knight C, Hind D, Brewer N, Abbott V.

Health Technol Assess. 2004 Sep;8(37):iii, ix-xi, 1-82. Review.

5.
6.

Effective immunochemotherapy for aggressive non-Hodgkin's lymphoma.

Coiffier B.

Semin Oncol. 2004 Feb;31(1 Suppl 2):7-11. Review.

PMID:
15042528
7.

Rituximab for the treatment of diffuse large B-cell lymphomas.

Held G, Pöschel V, Pfreundschuh M.

Expert Rev Anticancer Ther. 2006 Aug;6(8):1175-86. Review.

PMID:
16925484
8.

Immunochemotherapy: the new standard in aggressive non-Hodgkin's lymphoma in the elderly.

Coiffier B.

Semin Oncol. 2003 Feb;30(1 Suppl 2):21-7. Review.

PMID:
12652461
9.

Rituximab in the treatment of diffuse large B-cell lymphomas.

Coiffier B.

Semin Oncol. 2002 Feb;29(1 Suppl 2):30-5. Review.

PMID:
11842386
10.

Diffuse large B-cell lymphoma.

Ng AK.

Semin Radiat Oncol. 2007 Jul;17(3):169-75. Review.

PMID:
17591563
11.

Evolution of R-CHOP therapy for older patients with diffuse large B-cell lymphoma.

Morrison VA.

Expert Rev Anticancer Ther. 2008 Oct;8(10):1651-8. doi: 10.1586/14737140.8.10.1651. Review.

PMID:
18925856
12.

Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.

Guirguis HR, Cheung MC, Mahrous M, Piliotis E, Berinstein N, Imrie KR, Zhang L, Buckstein R.

Br J Haematol. 2012 Oct;159(1):39-49. doi: 10.1111/j.1365-2141.2012.09247.x. Epub 2012 Jul 31. Review.

PMID:
22849793
13.

Treatment of aggressive non-Hodgkin's lymphoma: a north American perspective.

Sehn LH, Connors JM.

Oncology (Williston Park). 2005 Apr;19(4 Suppl 1):26-34. Review.

14.

The best treatment for diffuse large B-cell lymphoma: a German perspective.

Schmits R, Schmitz N, Pfreundschuh M; German High-Grade Non-Hodgkin's Lymphoma Study Group.

Oncology (Williston Park). 2005 Apr;19(4 Suppl 1):16-25. Review.

15.

Treatment of the elderly patient with diffuse large B cell lymphoma.

Fields PA, Linch DC.

Br J Haematol. 2012 Apr;157(2):159-70. doi: 10.1111/j.1365-2141.2011.09011.x. Epub 2012 Jan 16. Review.

PMID:
22463486
16.

Diffuse large B-cell lymphoma.

Hunt KE, Reichard KK.

Arch Pathol Lab Med. 2008 Jan;132(1):118-24. doi: 10.1043/1543-2165(2008)132[118:DLBL]2.0.CO;2. Review.

PMID:
18181663
17.

Primary breast lymphoma.

Gholam D, Bibeau F, El Weshi A, Bosq J, Ribrag V.

Leuk Lymphoma. 2003 Jul;44(7):1173-8. Review.

PMID:
12916870
18.

Bcl-2 gene expression as a predictor of outcome in diffuse large B-cell lymphoma.

Shivakumar L, Armitage JO.

Clin Lymphoma Myeloma. 2006 May;6(6):455-7. Review.

PMID:
16796775
19.

Current treatment strategy of diffuse large B-cell lymphomas.

Niitsu N.

Int J Hematol. 2010 Sep;92(2):231-7. doi: 10.1007/s12185-010-0666-x. Epub 2010 Aug 28. Review.

PMID:
20803108
20.

Aspects of chemotherapy schedules in young and elderly patients with aggressive lymphoma.

Zwick C, Gleissner B, Pfreundschuh M.

Clin Lymphoma Myeloma. 2007 Dec;8 Suppl 2:S43-9. Review.

PMID:
18284715
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk